These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31344071)

  • 21. Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.
    Togneri FS; Allen SK; Mann K; Holgado E; Morgan S
    Genet Res (Camb); 2020 Sep; 102():e7. PubMed ID: 32867862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contingent cfDNA Screening Implementation: Increasing Diagnostic Accuracy and Reducing Invasive Testing - 6 Years' Results in a Single Center.
    Cubo AM; Huélamo M; Martín-Seisdedos MC; Hernández-Hernández E; Lapresa-Alcalde MV; Rodríguez-Martín MO; Doyague MJ; Sayagués JM
    Fetal Diagn Ther; 2022; 49(3):103-113. PubMed ID: 35259749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance and costs of contingent screening models for trisomy 21 incorporating non-invasive prenatal testing.
    Maxwell S; O'Leary P; Dickinson JE; Suthers GK
    Aust N Z J Obstet Gynaecol; 2017 Aug; 57(4):432-439. PubMed ID: 28369759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-free DNA screening for trisomy 21 in twin pregnancy: a large multicenter cohort study.
    Dugoff L; Koelper NC; Chasen ST; Russo ML; Roman AS; Limaye MA; Ranzini AC; Clifford CM; Biggio JR; Subramaniam A; Seasely A; Patil AS; Weed S; Page JM; Nicholas S; Idler J; Rao RR; Crowder A; Shree R; McLennan G; Bromley B
    Am J Obstet Gynecol; 2023 Oct; 229(4):435.e1-435.e7. PubMed ID: 37030426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [MODELS OF CLINICAL IMPLEMENTATION OF CELL FREE FETAL DNA IN THE MATERNAL SERUM SCREENING TEST-ANALYSIS].
    Yankova M; Chaveeva P; Stratieva V
    Akush Ginekol (Sofiia); 2015; 54(7):15-21. PubMed ID: 27025103
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequential integrated antenatal screening for Down's syndrome, trisomy 18 and trisomy 13.
    Bestwick JP; Wald NJ
    J Med Screen; 2016 Sep; 23(3):116-23. PubMed ID: 26498068
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.
    McLennan A; Palma-Dias R; da Silva Costa F; Meagher S; Nisbet DL; Scott F
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):22-8. PubMed ID: 26817523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contingent prenatal screening for frequent aneuploidies with cell-free fetal DNA analysis.
    Torres Aguilar MR; Carrasco Salas P; Santos Rosa C; Bueno Rodríguez G; Martínez-Bonet E; Carreto Alba P; León-Justel A; Granell Escobar MR
    Taiwan J Obstet Gynecol; 2021 Jul; 60(4):745-751. PubMed ID: 34247818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Massively Parallel Sequencing (MPS) of Cell-Free Fetal DNA (cffDNA) for Trisomies 21, 18, and 13 in Twin Pregnancies.
    Du E; Feng C; Cao Y; Yao Y; Lu J; Zhang Y
    Twin Res Hum Genet; 2017 Jun; 20(3):242-249. PubMed ID: 28485265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DNA sequencing versus standard prenatal aneuploidy screening.
    Bianchi DW; Parker RL; Wentworth J; Madankumar R; Saffer C; Das AF; Craig JA; Chudova DI; Devers PL; Jones KW; Oliver K; Rava RP; Sehnert AJ;
    N Engl J Med; 2014 Feb; 370(9):799-808. PubMed ID: 24571752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-Free DNA Analysis in Maternal Blood: Differences in Estimates between Laboratories with Different Methodologies Using a Propensity Score Approach.
    Bevilacqua E; Jani JC; Letourneau A; Duiella SF; Kleinfinger P; Lohmann L; Resta S; Cos Sanchez T; Fils JF; Mirra M; Benachi A; Costa JM
    Fetal Diagn Ther; 2019; 45(5):302-311. PubMed ID: 29898450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost effectiveness, the economic considerations of prenatal screening strategies for trisomy 21 in the Czech Republic.
    Dhaifalah I; Májek O
    Ceska Gynekol; 2012 Feb; 77(1):39-51. PubMed ID: 22536640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prenatal screening for trisomy 21: a comparative performance and cost analysis of different screening strategies.
    Huang T; Gibbons C; Rashid S; Priston MK; Bedford HM; Mak-Tam E; Meschino WS
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):713. PubMed ID: 33228595
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation.
    Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX
    DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improving the calling of non-invasive prenatal testing on 13-/18-/21-trisomy by support vector machine discrimination.
    Yang J; Ding X; Zhu W
    PLoS One; 2018; 13(12):e0207840. PubMed ID: 30517156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporating DNA sequencing into current prenatal screening practice for Down's syndrome.
    Wald NJ; Bestwick JP
    PLoS One; 2013; 8(3):e58732. PubMed ID: 23527014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined first trimester screen or noninvasive prenatal testing or both.
    Tan TY
    Singapore Med J; 2015 Jan; 56(1):1-3. PubMed ID: 25640091
    [No Abstract]   [Full Text] [Related]  

  • 38. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
    Audibert F; Gagnon A; ;
    J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IONA test for first-trimester detection of trisomies 21, 18 and 13.
    Poon LC; Dumidrascu-Diris D; Francisco C; Fantasia I; Nicolaides KH
    Ultrasound Obstet Gynecol; 2016 Feb; 47(2):184-7. PubMed ID: 26387684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. First trimester screening cut-offs for noninvasive prenatal testing as a contingent screen: Balancing detection and screen-positive rates for trisomy 21.
    Maxwell S; James I; Dickinson JE; O'Leary P
    Aust N Z J Obstet Gynaecol; 2016 Feb; 56(1):29-35. PubMed ID: 26749261
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.